Gastric cancer: Translating novels concepts into clinical practice
Salati, Orsi, Smyth et al
Cancer Treat. Rev. (2019) 79, 101889
Discovery of phosphonamidate IDO1 inhibitors for the treatment of non-small cell lung cancer
Du, Feng, Wang et al
Eur J Med Chem (2019) 182, 111629
Tumor Biology and Multidisciplinary Strategies of Oligometastasis in Gastrointestinal Cancers
Zhao, Li, Li et al
Semin. Cancer Biol. (2019)
The adjuvant treatment revolution for high-risk melanoma patients
Spagnolo, Boutros, Tanda et al
Semin. Cancer Biol. (2019)
Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172)
Nathan, Ascierto, Haanen et al
Eur. J. Cancer (2019) 119, 168-178
Challenging the recalcitrant disease-developing molecularly driven treatments for small cell lung cancer
Mak, Li, Minchom
Eur. J. Cancer (2019) 119, 132-150
Novel conjugates with dual suppression of glutathione S-transferases and tryptophan-2,3-dioxygenase activities for improving hepatocellular carcinoma therapy
Hua, Wang, Chen et al
Bioorg. Chem. (2019) 92, 103191
Unique T cell populations define immune-inflamed Hepatocellular Carcinoma
Di Blasi, Boldanova, Mori et al
Cell Mol Gastroenterol Hepatol (2019)
Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo
Schofield, Irving, Calo et al
Neurobiol. Dis. (2019)
Sublingual immunotherapy and omalizumab cured allergic chronic rhinosinusitis and asthma: coincidence or synergistic effect?
Konstantinou, Kaitalidou, Skoulikaris
Ann. Allergy Asthma Immunol. (2019)
E2 ubiquitin-conjugating enzymes in cancer: Implications for immunotherapeutic interventions
Hosseini, Okoye, Chaleshtari et al
Clin. Chim. Acta (2019)
Activation of human vascular endothelium in melanoma metastases induces ICAM-1 and E-selectin expression and results in increased infiltration with effector lymphocytes
Weishaupt, Steinert, Brunner et al
Exp. Dermatol. (2019)
Immunotherapy: Checkpoint Inhibitors in Lynch-Associated Gynecologic Cancers
Ferriss, Williams-Brown
Curr Treat Options Oncol (2019) 20, 75
Morphomolecular analysis of the immune tumor microenvironment in human head and neck cancer
Badr, Jöhrens, Allgäuer et al
Cancer Immunol. Immunother. (2019)
TRPM7 mediates kidney injury, endothelial hyperpermeability and mortality during endotoxemia
Gatica, Villegas, Vallejos et al
Lab. Invest. (2019)
Single-cell profiling guided combinatorial immunotherapy for fast-evolving CDK4/6 inhibitor-resistant HER2-positive breast cancer
Wang, Guldner, Golomb et al
Nat Commun (2019) 10, 3817
Programmed Cell Death Ligand 1 in Breast Cancer: Technical Aspects, Prognostic Implications, and Predictive Value
Miglietta, Griguolo, Guarneri et al
Oncologist (2019)
Clinical Efficacy and Tumor Microenvironment Influence in a Dose-Escalation Study of Anti-CD19 Chimeric Antigen Receptor T Cells in Refractory B-Cell Non-Hodgkin's Lymphoma
Yan, Li, Wang et al
Clin. Cancer Res. (2019)
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update
Babjuk, Burger, Compérat et al
Eur. Urol. (2019)
Does a polarization state exist for mast cells in cancer?
Presta, Donato, Zaffino et al
Med. Hypotheses (2019) 131, 109281